Clinical Trial

Erector Spinae Plane Block Versus Transcutaneous Radiofrequency in Postherpetic Neuralgia

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 25, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This observational study aims to compare the effectiveness of ultrasound-guided erector spinae plane (ESP) block and transcutaneous radiofrequency (RF) treatment in patients with postherpetic neuralgia. Pain intensity and neuropathic pain characteristics will be evaluated using the Visual Analog Scale (VAS) and the Self-Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) score.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-03.
Trial Details
NCT Number NCT07400640
Lead Sponsor Diskapi Teaching and Research Hospital
Conditions Postherpetic Neuralgia, Neuropathic Pain, Herpes Zoster
Enrollment 50 participants
Start Date 2025-06-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-25